Cary Miller, Ph.D, Pablo D. Hendler and M. Andrew Woodmansee join Jones Day's Intellectual Property Practice

Saturday, February 27, 2016 - 13:38

The global law firm Jones Day has announced that three intellectual property partners have joined the Firm's Global Intellectual Property PracticeM. Andrew Woodmansee and Cary Miller, Ph.D., who most recently were partners with Morrison & Foerster, join Jones Day’s San Diego officePablo D. Hendler, who arrives from Ropes & Gray, joins Jones Day’s New York office.

"We are pleased to welcome these three outstanding lawyers to our Global Intellectual Property team, which consists of more than 230 lawyers across the U.S., Europe, and Asia," said Anthony M. Insogna, Practice Leader of Jones Day’s Global Intellectual Property Practice. "Cary, Drew, and Pablo each bring with them a unique set of skills and tremendous experience with patent litigation for life sciences companies. These talented partners will strengthen our Hatch-Waxman and Biosimilars capabilities in two very important markets for our clients: New York and California." 

Mr. Woodmansee, who was most recently head of the Litigation Department in Morrison & Foerster’s San Diego office, is a nationally known patent litigator with 20 years of experience. He has represented clients in the pharmaceutical, biotechnology, medical device, and telecommunications industries in federal courts throughout the U.S., including companies such as Hologic Gen-Probe, Dexcom, Palm, Kyocera, EchoStar Communications/DISH Network, and Charter Communications. Mr. Woodmansee has tried cases to verdict for life sciences clients in both bench and jury trials, and he has successfully handled Section 337 investigations before the U.S. International Trade Commission. Mr. Woodmansee recently served a four year term as a Lawyer Representative to the U.S. District Court for the Southern District of California, has served as a faculty member for the National Institute of Trial Advocacy, and has lectured on patent law at the University of San Diego Law School. Mr. Woodmansee received a bachelor’s degree from the University of Notre Dame and earned his J.D. from Notre Dame Law School.

Dr. Miller has been representing clients in the biotechnological and pharmaceutical industries for more than 13 years. Her experience is in the areas of creating strategic patent portfolios, advising on pre-litigation patent infringement and validity issues, USPTO post-grant proceedings, and patent litigation. She has experience in both Hatch-Waxman and Biosimilars litigation. Best Lawyers named Dr. Miller the "San Diego Biotechnology Law Lawyer of the Year" for 2013, an honor given to a single lawyer in the metropolitan area. Before receiving her J.D. from Columbia Law School, Dr. Miller received her Ph.D. in biomedical sciences from Mount Sinai School of Medicine in New York, where her primary area of research was in cellular, developmental and molecular biology, and her undergraduate degree in life sciences from Queen’s University in Canada.

"Drew and Cary are both well respected lawyers in the San Diego community and we're so delighted to have them join Jones Day to help us continue our growth in the market," said Karen Hewitt, Partner-in-Charge of Jones Day's San Diego Office. "With their arrival, this office has grown over the last 12 years from just one lawyer to a team of more than 50 in multiple areas of practice, including more than 25 IP lawyers and patent agents."

"Lawyers of this caliber have a large number of options for where they'd like to practice, so we're very gratified they chose to join our Global IP team here in California," said Chris Lovrien, Partner-in-Charge of the California Region for Jones Day. “Our clients will benefit richly from Cary and Drew's experience working on high-stakes IP matters in a wide range of industries. We are committed to growing our IP Practice in California and these lawyers have tremendous reputations throughout the state. "

Mr. Hendler has significant experience representing some of the world's leading pharmaceutical companies in Hatch-Waxman patent litigation, including Purdue Pharma and Astrazenca. Jones Day's Life Sciences patent litigation group counts among its many clients Abbvie, Biomarin, Celgene and Purdue, and Pablo's addition further strengthens the Firm's New York Hatch-Waxman group. Mr. Hendler offers a unique combination of skills as a chemical engineer, inventor, and attorney with more than 20 years of experience handling patent infringement matters -- most of which have been primarily focused on pharmaceutical and medical device litigation. His litigation experience includes serving as lead counsel on major pharmaceutical products including at preliminary injunction proceedings, trials, and appeals. Mr. Hendler earned his undergraduate degree in chemical engineering from The University of Michigan and his J.D. from Northwestern University School of Law.

"Pablo brings with him a perspective that will be of great value to our clients, in particular his experience with Hatch-Waxman litigation, which is of special importance to clients in the New York legal market,” said Wesley Johnson Jr., Partner-in-Charge of Jones Day’s New York Office. "He will be a great asset to our IP team here in New York, which works with our Jones Day colleagues around the world to help solve our clients' IP problems and to protect, enhance, and maximize the value of their global IP assets."